Access cutting-edge duchenne muscular dystrophy treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.
Access duchenne muscular dystrophy specialists in Portland at no cost
This study follows strict safety protocols and ethical guidelines
All study-related duchenne muscular dystrophy treatment provided free
This is a multicenter, open-label, non-randomized study to investigate the safety, tolerability, and efficacy of a single intravenous (IV) infusion of SGT-003 in participants with Duchenne muscular dystrophy. There will be 5 cohorts in this study. Cohort 1 will include participants 4 to \< 7 years of age. Cohort 2 will include participants 7 to \< 12 years of age. Cohort 3 will include participants 0 to \< 4 years of age. Cohort 4 will include participants 12 to \< 18 years of age. Cohort 5 will
Sponsor: Solid Biosciences Inc.
Check if you qualify for this duchenne muscular dystrophy clinical trial in Portland, OR
If you're searching for duchenne muscular dystrophy treatment options in Portland, OR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced duchenne muscular dystrophy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.